Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats

Cell Biochemistry and Function

Volumn 32, Issue 3, 2014, Pages 287-293

  Mushtaq, Nadia ^a   Schmatz, Roberta ^a   Pereira, Luciane B ^a   Ahmad, Mushtaq ^b   Stefanello, Naiara ^a   Vieira, Juliano M ^a   Abdalla, Fátima ^a   Rodrigues, Marília V ^a   Baldissarelli, Jucimara ^a   Pelinson, Luana Paula ^a   Dalenogare, Diéssica P ^a   Reichert, Karine Paula ^a   Dutra, Eduardo M ^a   Mulinacci, Nádia ^c   Innocenti, Marzia ^c   Bellumori, Maria ^c   Morsch, Vera Maria ^a   Schetinger, Maria Rosa ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b University of Science and Technology   (Pakistan)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acetylcholinesterase; Diabetes; Lipid peroxidation; Rosmarinic acid; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; ALCOHOL; GLUCOSE; ROSMARINIC ACID; STREPTOZOCIN; ANTIOXIDANT; CINNAMIC ACID DERIVATIVE; DEPSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APATHY; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; LETHARGY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS;

ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; BRAIN; CINNAMATES; DEPSIDES; DIABETES MELLITUS, EXPERIMENTAL; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84898043844     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3014     Document Type: Article

References (52)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(Supplement-1): S62-S67.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
3. Bonnefont RD, Bastard JP, Jaudon MC, et al. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163-176.
4. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279(41): 42351-42354.
5. Nohl H. Involvement of free radical in ageing: a consequence or cause of senescence. Br Med Bull 1991; 49: 653-667.
6. Franco R, Bortner CD, Cidlowski JA. Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis. J Membrane Biol 2006; 209: 43-58.
7. Semiz A, Sen A. Antioxidant and chemoprotective properties of Momordicacharantia L. (bitter melon) fruit extract. Afr J Biotechnol 2007; 6(3): 273-277.
8. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212.
9. Uttara B, Singh AV, Zamboni P, et al. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009; 7: 65-74.
10. Sima AAF, Kamiya H, Lia ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490: 187-197.
11. Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61: 661-666.
12. Manschot SM, Biessels JG, Cameron NE, et al. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res 2003; 966: 274-282.
13. Kamboj SS, Chopra K, Sandhir R. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab Brain Dis 2008; 23: 427-43.
14. Kuhad A, Sethi R, Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 2008; 83: 128-134.
15. Schmatz R, Mazzanti CM, Spanevello R, et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009; 610: 42-48.
16. Soreq H, Seidman S. Acetylcholinesterase - new roles for an old actor. Nat Rev Neurosci 2001; 2: 294-302.
17. Li B, Stribley J, Ticu A, Xic W, et al. Abundant tissue butyrylcholinesterase and its possiblefunction in the acetylcholinesterase knockout mouse. J Neurochem 2000; 75: 1320-31.
18. Ragoobirsingh D, Bhraj BS, Morrison EY. Changes in serum cholinesterases activity in Jamaican diabetes. J Na Med Assoc 1992; 84: 853-855.
19. Rizvi SI, Zaid MA. Insulin like effect of (-) epicatechein on erythrocyte membrane acetyl cholinesterases in type 2 diabetes mellitus. Clin Exp Pharmacol Physiol 2001; 28: 776-778.
20. Myojin C, Enami N, Nagata A, et al. Changes in the Radical-Scavenging Activity of Bitter Gourd (Momordica charantia L.) during Freezing and Frozen Storage with or without Blanching. J Food Sci 2008; 73(7): 546-550.
21. Aher VD, Wahi A, Pawdey AM. Antioxidants as immunomodulator: an expanding research avenue. Int J Curr Pharm Res 2011; 3: 8-10.
22. Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem 2001; 49: 5165-70.
23. Wang H, Provan GJ, Helliwell K. Determination of rosmarinic acid and caffeic acid in aromatic herbs by HPLC. Food Chem 2004; 87: 307-11.
24. Lu YR, Foo LY. Rosmarinic acid derivatives from Salvia officinalis. Phytochemistry 2000; 55: 263-67.
25. Kochan E, Wysokinska H, Chmiel A, et al. Romarinic acid and other phenolic acids in hairy roots of Hyssopus officinalis. Z Naturforsch 1999; 54: 11-16.
26. Petersen M, Simmonds MS. Rosmarinic acid. Phytochemistry 2003; 62(2): 121-5.
27. Schmatz R, Perreira LB, Stefanello N, et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 2012; 94: 374-83.
28. Khaki AA. Effect of rosmarinic acid on sexual behavior in diabetic male rats. Af J PharmPharmacol 2011; 5(16): 1906-1910.
29. Ghasemzadeh A, Khaki A, Farzadi L, et al. Effect of rosmarinic acid on estrogen, FSH and LH in female diabetic rats Afr. J PharmPharmacol 2011; 5(11): 1427-1431.
30. Bradford MM. A rapid and sensitive method for quantification of microgramquantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
31. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
32. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70e77.
33. Rocha JBT, Emanuelli T, Pereira ME. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobio Exp 1993; 53: 431-437.
34. Maritim AC, Sandres RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-39.
35. Huan WY. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2008; 40: 1-5.
36. Chatterjee MN, Shinde R. Textbook of Medical Biochemistry. Jaypee Brothers, Medical Publishers Pvt. Ltd: New Delhi, 2002; 317.
37. Hakim ZS, Patel BK, Goyal RK. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats. India J Physiol Pharmacol 1997; 41: 353-360.
38. Chen CT, Green JT, Orr SK, et al. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot Essent Fatty Acids 2008; 79: 85-91.
39. Kumawat M, Singh I, Singh N, et al. Lipid Peroxidation and Lipid Profile in Type II Diabetes Mellitus. Webmed Central Biochemistry 2012; 3(3): WMC003147
40. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996; 36: 83-106.
41. Kikuchi S, Shinpo K, Takeuchi M, et al. Glycation-a sweet tempter for neuronal death. Brain Res Brain Res Rev 2003; 41: 306-23.
42. Mehta A. Chlorpyrifos-induced alterations in rat brain acetylcholinesterase, lipid peroxidation and ATPases. Indian J Biochem Biophys 2005; 42: 54-58.
43. Sánchez-Chávez G, Salceda R. Acetyl- and butyrylcholinesterase in normal and diabetic rat retina. Neurochem Res 2001; 26(2): 153-9.
44. Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates hyperglycemia mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem Biol Interact 2010; 186: 200-210.
45. Rao AA, Sridhar GR, Das UN. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med Hypotheses 2007; 69: 1272-1276.
46. Sreedhar G, Thota H, Allam AR, et al. Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection? Lipids Health Dis 2006; 5: 28.
47. Bito N, Fukushima S, Hasegawa A, et al. Carcinogenicity of buthylatedhydroxyanisole in F344 rats. J Nat Cancer Inst 1983; 70: 343-347.
48. Ates O, Cayli SR, Yucel N, et al. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci 2007; 14: 256-260.
49. Pandey KB, Rizvi SI. Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress. Appl Physiol Nut Metab 2009; 34: 1093-1097.
50. Iuvone T, De Filippis D, Esposito G, et al. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 2006; 317: 1143-1149.
51. Elufioye TO, Obuotor EM, Sennuga AT, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some selected Nigerian medicinal plants. Braz J Pharmacognosy 2010; 20(4): 472-477.
52. Aldunate R, Casar JC, Brandan E, et al. Structural and functional organization of synaptic acetylcholinesterase. Brain Res Brain Res Rev 2004; 47: 96-104.